저자: VictorH · 외국인
요약 보기
마이클 버리의 2025년 포트폴리오가 중국(알리바바, JD 등)과 헬스케어(몰리나, 오스카헬스 등) 집중 투자로 잘 수익을 내고 있다고 분석. 알리바바는 연초 대비 65% 상승했지만 FCF 기준 약 14% 할인 상태로 여전히 매수 의견이며, 중국 경제가 수출을 통해 성장할 것으로 전망. 오스카헬스는 소형주이나 성장성이 높고 약 61% 할인으로 평가되어 직접 매수 중이라고 밝힘. 버리의 2025년 성과가 본 적 없는 최고 수준이라 계속 추적하겠다고 언급.
다듬은 글
one of the most famous investors out there is Michael bur he's the one behind the movie The Big Short and it was a fun movie to watch but more importantly he really made a great call on shorting the subprime market for mortgages and he became very famous and very wealthy very respected I wanted to take a look at his portfolio and see what he's investing in and see if I can draw some comparisons to my portfolio and see where he's going see if I can learn something become a better investor for 2025 he's got some positions that are very concentrated in two areas the first one is China if you look at his Investments he's got a significant position in Alibaba BYU JD pind Doo and those are four of his top seven positions in his portfolio China makes up about 52% of his portfolio so he's really betting big on China which isn't a bad idea in 2025 I'll show you year to dat results for his top Holdings and you'll see that he's doing really well in 2025 because of China the other area is Healthcare he's got over 24% of his portfolio invested in healthc care he's got Molina health care HCI healthc care Brooker and Oscar Health these are really solid positions and in the case of Oscar this is a real small company and Healthcare is doing really well it's the top performing sector in the United States so he's two for two his portfolio must be just crushing the first quarter of 2025 while technology focused uh funds are probably really suffering big losses the top five positions in his portfolio are doing quite well with the exception of one um Alibaba is up 65% and we're 2 and a half months into the year Buu up 12% JD up 22% Lauder which is a consumer discretionary stock that's down 2% you can't be perfect I guess and Molina Healthcare is up 12% and Oscar I know Oscar is up about 18% because I'm an Oscar Health investor so he is cleaning up in 2025 just a really successful bet on China and healthc Care Alibaba is one of my big positions and it's doing really well it's up 65% year to date it has a market cap of $317 billion and that's really makes sense because this is the biggest publicly traded stock in China China is the second biggest economy in the world growing faster than uh the economy here in the US is growing so it's a great place to be the Ford p is only 14 and it's a strong buy according to the analyst overall I have a buy on Alibaba I still think it's disc counted just by a little bit and overall I think this stock is going to continue to work in 2025 because the China economy I expect is going to do really well exporting to around the world and exporting to Latin America Africa middle east Europe all these different places they don't have to depend on the US to grow they can grow around the world and be very competitive if you watch my channel you know that I discount companies based on their free cash flows and trying to get an intrinsic value of those companies based on free cash flows and I also look at earnings per share and when I look at Alibaba I have a 14% discount on the stock and so it's gone up 65% in 2025 it had a good 2024 and I think it has more room to run the fundamentals of Ali Baba will continue to improve and this valuation will continue to change I do it at least once a quarter especially around their earnings I might update the valuation twice a quarter so this is my most current valuation of Alibaba it is still a buy for me and it's discounted by 14% a lesser known company is Oscar Health but boy it's really been picking up value in 2025 it's up 18.75% year to date it is a tiny cap four billion and its revenue is 9.18 billion this is a health insurance company focused on small business businesses and individuals which is I think a category that Oscar Health can really grow in because the big guys you know Healthcare and others they don't want to touch the small business area so they leave it up to companies like Oscar Health to to take care of so I think they don't have a lot of competition against the big strong players in the space I think they're going to grow for some time maybe get up to 2030 billion dollar in revenue and I think they're value valtion is going to double triple over the next year Oscar Health has terrific growth and based on that growth and the fact that they're already cash positive and profitable I have a valuation on the stock that puts them at a 61% discount so I am buying shares of Oscar Health trying to build a big position in Oscar health so far so good in 2025 I'll continue to buy shares in this really high growth business so Michael bur is really making the right calls in 2025 and I'm going to keep following his portfolio for a while I have to admit his portfolio didn't make sense to me a couple years ago I think he was in sectors that didn't quite work and but now in 2025 boy he's really cleaning up he might be the best performer for 2025 that I've seen I haven't seen him all right but I've reviewed bill aan I reviewed Warren Buffett I've re reviewed uh Pat dorsy as well as a few others and this portfolio is the one that's performing the best so I'm going to keep a close eye on it so that's my video on Michael bur I hope you found it interesting and I appreciate you watching please leave a comment let me know what you think of Michael Bur
Comments 0